Literature DB >> 9209175

Influence of the SstI polymorphism at the apolipoprotein C-III gene locus on the plasma low-density-lipoprotein-cholesterol response to dietary monounsaturated fat.

J López-Miranda1, S Jansen, J M Ordovas, J Salas, C Marín, P Castro, M A Ostos, G Cruz, F López-Segura, A Blanco, J Jiménez-Perepérez, F Pérez-Jiménez.   

Abstract

The plasma lipid response to changes in dietary fat and cholesterol can vary between individuals. The SstI polymorphism, arising from a cytosine to guanosine substitution in the 3' untranslated region of the APOC3 gene distinguishes between two alleles--S1 and S2. The S2 allele has been associated with elevated plasma triacylglycerol, cholesterol, and apolipoprotein (apo) C-III concentrations. In 90 young men we examined the effect of the same mutation on the response of low-density-lipoprotein (LDL) cholesterol to dietary monounsaturated fat. The frequency for the S2 allele was 0.14. Subjects were fed a low-fat diet for 25 d, followed by a diet rich in monounsaturated fatty acid (22% MUFA, 38% total fat) for 28 d; lipoproteins were measured at the end of each diet. There were no significant differences in initial total cholesterol between subjects with the APOC3*S1/APOC3*S1 (S1/S1) and APOC3*S1/APOC3*S2 (S1/S2) genotypes. After consumption of the diet high in MUFA, significant increases in LDL cholesterol (0.13 mmol/L, P < 0.027) were noted in the S1/S1 subjects whereas a significant decrease was observed in the S1/S2 subjects (-0.18 mmol/L, P < 0.046). Significant genotypic effects were seen for diet-induced changes in LDL cholesterol (P < 0.00034), total cholesterol (P < 0.009), and apo B (P < 0.0014). A study of the effect of the interaction between this mutation with that present in position -76 of the APOA1 gene promoter region (G/A) revealed that both mutations had an additive effect on changes in total cholesterol, LDL cholesterol, and apo B induced by diets. Plasma LDL-cholesterol responsiveness to the diet may be explained, at least in part, by variation at the APOC3 gene locus.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9209175     DOI: 10.1093/ajcn/66.1.97

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  7 in total

1.  Genetics of cardiovascular disease.

Authors:  Rosanna Abbate; Elena Sticchi; Cinzia Fatini
Journal:  Clin Cases Miner Bone Metab       Date:  2008-01

2.  Association of lipoprotein lipase and apolipoprotein C-III genes polymorphism with acute myocardial infarction in diabetic patients.

Authors:  Tarek A Abd El-Aziz; Rasha H Mohamed; Reem M Hashem
Journal:  Mol Cell Biochem       Date:  2011-04-17       Impact factor: 3.396

3.  Contribution of polymorphisms in the apolipoprotein AI-CIII-AIV cluster to hyperlipidaemia in patients with gout.

Authors:  F Cardona; F J Tinahones; E Collantes; A Escudero; E García-Fuentes; F J Soriguer
Journal:  Ann Rheum Dis       Date:  2004-04-28       Impact factor: 19.103

4.  Treatment of dyslipidemia: genetic interactions with diet and drug therapy.

Authors:  J M Ordovas; E J Schaefer
Journal:  Curr Atheroscler Rep       Date:  1999-07       Impact factor: 5.967

Review 5.  Genetic predictors of plasma lipid response to diet intervention.

Authors:  J M Ordovas; J R Galluzzi
Journal:  Curr Atheroscler Rep       Date:  1999-11       Impact factor: 5.967

6.  Associations of the APOC3 rs5128 polymorphism with plasma APOC3 and lipid levels: a meta-analysis.

Authors:  Yongyan Song; Liren Zhu; Mudwari Richa; Ping Li; Yang Yang; Suping Li
Journal:  Lipids Health Dis       Date:  2015-04-18       Impact factor: 3.876

Review 7.  Apolipoprotein C-III and cardiovascular diseases: when genetics meet molecular pathologies.

Authors:  Israa Dib; Alia Khalil; Racha Chouaib; Yolla El-Makhour; Hiba Noureddine
Journal:  Mol Biol Rep       Date:  2021-01-03       Impact factor: 2.316

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.